Chinese investment in the UK’s leading companies has surged to almost £90bn amid fears that Beijing is buying up Britain.

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

Glaxosmithkline Pharmaceuticals Ltd, Marico Ltd, Caplin Point Laboratories Ltd and Aarti Pharmalabs Ltd are among the other losers in the BSE's 'A' group today, 21 April 2025.

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management TeamZevra Continues Growth Trajectory into a ...

France, long recognized as a global leader in cosmetic innovation and export, plays a pivotal role in the retinoid market. The French retinoid industry is growing at the fastest pace in Europe, with a ...

China has been quietly increasing its hold on some of the UK’s most valuable companies. According to recent research, Chinese ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

Pharmaceutical bosses and the government are racing to stop Donald Trump slapping tariffs on medicines in a move that would ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2916. The stock has experienced fluctuations ...